UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Kangaroo Mother Care to Prevent Hypothermia in Preterm Infants

Not Applicable

Completed

Conditions: Hypothermia, Newborn

Interventions: Other: Continuous Kangaroo Mother Care to 1 hour after birth
Other: Continuous Kangaroo Mother Care to discharge
Other: Standard Kangaroo Mother Care to 1 hour after birth
Other: Standard Kangaroo Mother Care to discharge

First Posted Date: 2014-07-15

Last Posted Date: 2018-01-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 140

Registration Number: NCT02189746

Locations: 🇿🇲
University Teaching Hospital, Lusaka, Zambia

Kangaroo Mother Care to Prevent Hypothermia in Term Infants

Not Applicable

Completed

Conditions: Newborn
Hypothermia

Interventions: Other: Standard Kangaroo Mother Care to one hour after birth
Other: Continuous Kangaroo Mother Care to discharge
Other: Standard Kangaroo Mother Care to discharge
Other: Continuous Kangaroo Mother Care to one hour after birth

First Posted Date: 2014-07-15

Last Posted Date: 2017-06-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 375

Registration Number: NCT02189759

Locations: 🇿🇲
University Teaching Hospital, Lusaka, Zambia

Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study

Not Applicable

Completed

Conditions: Scoliosis

Interventions: Other: Control
Other: Chewing gum

First Posted Date: 2014-06-17

Last Posted Date: 2014-06-17

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 83

Registration Number: NCT02165436

Locations: 🇺🇸
The Children's Hospital of Alabama, Birmingham, Alabama, United States

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Not Applicable

Completed

Conditions: Metastatic Triple Negative Breast Cancer

Interventions: Drug: Combination of Veliparib + Lapatinib

First Posted Date: 2014-06-09

Last Posted Date: 2025-02-03

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 23

Registration Number: NCT02158507

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors

Not Applicable

Completed

Conditions: Cancer

First Posted Date: 2014-05-29

Last Posted Date: 2016-02-09

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 46

Registration Number: NCT02150148

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

Phase 4

Completed

Conditions: Osteoporosis

Interventions: Drug: Alendronate

First Posted Date: 2014-05-15

Last Posted Date: 2017-05-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 27

Registration Number: NCT02139007

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

TOPIC Trial for COPD

Early Phase 1

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Placebo
Drug: Ivacaftor

First Posted Date: 2014-05-12

Last Posted Date: 2017-02-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT02135432

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

Completed

Conditions: End Stage Renal Disease

First Posted Date: 2014-05-08

Last Posted Date: 2017-04-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 49

Registration Number: NCT02133313

Locations: 🇺🇸
University of Alabama at Birmingham Home Dialysis Unit (Red Mountain Home Dialysis), Birmingham, Alabama, United States

Vascular Reparative Mechanism in Diabetes

Active, not recruiting

Conditions: Diabetic Retinopathy

Interventions: Other: Diabetic Patients
Other: Healthy Controls

First Posted Date: 2014-04-22

Last Posted Date: 2024-10-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 78

Registration Number: NCT02119689

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States

Low Dose Naltrexone (LDN) Immune Monitoring

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Drug: Low Dose Naltrexone

First Posted Date: 2014-04-08

Last Posted Date: 2017-04-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 9

Registration Number: NCT02107014

Locations: 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy